HWAM
RARE icon

Hennion & Walsh Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Hennion & Walsh Asset Management’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$850K Sell
25,456
-34,852
-58% -$866K 0.02% 608
2026
Q1 		$1.26M Sell
60,308
-1,865
-3% -$42K 0.04% 457
2025
Q4 		$1.43M Sell
62,173
-11,621
-16% -$382K 0.05% 431
2025
Q3 		$2.22M Buy
73,794
+3,157
+4% +$94.7K 0.08% 314
2025
Q2 		$2.57M Buy
70,637
+9,477
+15% +$342K 0.1% 257
2025
Q1 		$2.21M Sell
61,160
-2,060
-3% -$85.7K 0.1% 250
2024
Q4 		$2.66M Sell
63,220
-14,875
-19% -$738K 0.12% 215
2024
Q3 		$4.34M Buy
78,095
+4,806
+7% +$245K 0.2% 119
2024
Q2 		$3.01M Buy
73,289
+23,752
+48% +$1.01M 0.15% 166
2024
Q1 		$2.31M Buy
49,537
+14,159
+40% +$668K 0.12% 227
2023
Q4 		$1.69M Buy
35,378
+15,627
+79% +$606K 0.1% 274
2023
Q3 		$704K Buy
19,751
+1,426
+8% +$56.5K 0.04% 435
2023
Q2 		$845K Buy
18,325
+363
+2% +$16.8K 0.05% 403
2023
Q1 		$720K Buy
17,962
+3,048
+20% +$131K 0.04% 430
2022
Q4 		$691K Buy
+14,914
New +$587K 0.04% 418

Other funds holding RARE

AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM

Hennion & Walsh Asset Management's RARE Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its Ultragenyx Pharmaceutical (RARE) stake by 58% in Q2 2026, selling an estimated $866K and leaving 25,456 shares worth $850K. The position accounts for 0.02% of the portfolio, ranked #608.

Hennion & Walsh Asset Management first reported a position in RARE in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.34M in Q3 2024. 39 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Hennion & Walsh Asset Management held 25,456 shares of Ultragenyx Pharmaceutical worth $850K as of Q2 2026.
  • Hennion & Walsh Asset Management sold 34,852 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $866K.
  • Ultragenyx Pharmaceutical made up 0.02% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #608 holding.
  • Hennion & Walsh Asset Management first reported a position in Ultragenyx Pharmaceutical in Q4 2022 and has held it in 15 quarters since.
  • Hennion & Walsh Asset Management's Ultragenyx Pharmaceutical position peaked at $4.34M in Q3 2024.
  • 39 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.